On Friday, Alto Neuroscience Inc. (NYSE: ANRO) was 5.81% up from the session before settling in for the closing price of $4.13. A 52-week range for ANRO has been $4.04 – $24.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -50.00%. When this article was written, the company’s average yearly earnings per share was at 72.85%. With a float of $22.18 million, this company’s outstanding shares have now reached $26.88 million.
Let’s determine the extent of company efficiency that accounts for 63 employees. In terms of profitability, gross margin is 22.31%, operating margin of -14572.58%, and the pretax margin is -13388.44%.
Alto Neuroscience Inc. (ANRO) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Alto Neuroscience Inc. stocks. The insider ownership of Alto Neuroscience Inc. is 17.74%, while institutional ownership is 68.21%. The most recent insider transaction that took place on Jul 09 ’24, was worth 152,085. In this transaction CHIEF MEDICAL OFFICER of this company bought 12,069 shares at a rate of $12.60, taking the stock ownership to the 36,920 shares. Before that another transaction happened on Jul 10 ’24, when Company’s CHIEF MEDICAL OFFICER bought 2,931 for $13.22, making the entire transaction worth $38,748. This insider now owns 39,851 shares in total.
Alto Neuroscience Inc. (ANRO) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 72.85% per share during the next fiscal year.
Alto Neuroscience Inc. (NYSE: ANRO) Trading Performance Indicators
You can see what Alto Neuroscience Inc. (ANRO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 19.85.
Technical Analysis of Alto Neuroscience Inc. (ANRO)
Looking closely at Alto Neuroscience Inc. (NYSE: ANRO), its last 5-days average volume was 4.55 million, which is a jump from its year-to-date volume of 0.36 million. As of the previous 9 days, the stock’s Stochastic %D was 1.90%. Additionally, its Average True Range was 1.38.
During the past 100 days, Alto Neuroscience Inc.’s (ANRO) raw stochastic average was set at 3.23%, which indicates a significant decrease from 3.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 503.28% in the past 14 days, which was higher than the 207.98% volatility it showed in the past 100 days.
However, in the short run, Alto Neuroscience Inc.’s stock first resistance to watch stands at $4.58. Second resistance stands at $4.80. The third major resistance level sits at $5.12. If the price goes on to break the first support level at $4.04, it is likely to go to the next support level at $3.72. Now, if the price goes above the second support level, the third support stands at $3.50.
Alto Neuroscience Inc. (NYSE: ANRO) Key Stats
There are 26,884K outstanding shares of the company, which has a market capitalization of 117.82 million. As of now, sales total 0 K while income totals -36,310 K. Its latest quarter income was 0 K while its last quarter net income were -16,030 K.
